Actuate Therapeutics, Inc. Income Statement

Income Statement Dec2023 Dec2024
Revenue & cost
Revenue -0.04M-0.02M
Gross Profit -0.04M-0.02M
Operating items
Research & Development 21.71M18.68M
Selling, General & Administrative 3.27M6.48M
Operating Expenses 24.97M25.16M
Operating Income -24.97M-25.16M
EBIT -24.97M-25.16M
Non-operating items
Interest & Investment Income 0.35M0.22M
Non Operating Income 0.23M-2.12M
Net income details
EBT -24.66M-24.96M
Profit After Tax -24.74M-27.29M
Income from Continuing Operations -24.66M-24.96M
Consolidated Net Income -24.66M-24.96M
Income towards Parent Company -24.66M-24.96M
Net Income towards Common Stockholders -24.66M-24.96M
Additional items
EPS (Basic) -0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M
Shares Outstanding (Weighted Average) 16.22M19.53M
EBITDA -24.97M-25.16M